WHO ICTRP trial
Ginger Tablets effect on gestational diabetes
IRCT2015090523897N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015090523897N1 |
|---|---|
| Public title | Ginger Tablets effect on gestational diabetes |
| Scientific title | Double blinded Clinical trial of comparison between the effect of ginger and placebo on blood glucose in the women with gestational diabetes in two groups of ginger and placebo |
| Primary sponsor | Vice chancellor for research of Tarbiat Modares University |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Gestational diabetes. Diabetes mellitus arising in pregnancy;Diabetes mellitus arising in pregnancy |
| Interventions | Intervention 1: Intervention group will take ginger tablets which made by dineh company and contain 500 milligram of ginger, they will use 1500 milligram daily for 6 weeks. Intervention 2: Control groups take placebo tablets in dose 500… |
| Registration date | May 10, 2016 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: